Genetic heterogeneity of polycystic kidney disease in Bulgaria. 1995

N Bogdanova, and B Dworniczak, and D Dragova, and V Todorov, and D Dimitrakov, and K Kalinov, and J Hallmayer, and J Horst, and L Kalaydjieva
Institut für Humangenetik der Universität, Münster, Germany.

Linkage analysis was performed on 22 Bulgarian families with polycystic kidney disease (PKD) ascertained through the hemodialysis centers of two medical schools. A total of 128 affected and 59 unaffected individuals, and 54 spouses have been investigated using eight polymorphic markers linked to PKD1 and nine markers to PKD2. The results demonstrate locus heterogeneity with 0.67 as the maximum likelihood value of alpha, i.e., the proportion of families linked to PKD1. In five families, the results suggest linkage to PKD2 and observed recombinants place the gene between loci D4S1544 and D4S1542. In one family, two double recombinants for closely linked markers on chromosome 16 and on chromosome 4 give evidence for the lack of linkage to either PKD1 or PKD2, thus suggesting the involvement of a third locus. Analysis of clinical data in the PKD1 group versus the unlinked group shows no significant differences in the severity of the disease.

UI MeSH Term Description Entries
D008126 Lod Score The total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for "logarithmic odds." Lod Scores,Score, Lod,Scores, Lod
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D002031 Bulgaria A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey. The capital is Sofia.
D003625 Data Collection Systematic gathering of data for a particular purpose from various sources, including questionnaires, interviews, observation, existing records, and electronic devices. The process is usually preliminary to statistical analysis of the data. Data Collection Methods,Dual Data Collection,Collection Method, Data,Collection Methods, Data,Collection, Data,Collection, Dual Data,Data Collection Method,Method, Data Collection,Methods, Data Collection
D005260 Female Females

Related Publications

N Bogdanova, and B Dworniczak, and D Dragova, and V Todorov, and D Dimitrakov, and K Kalinov, and J Hallmayer, and J Horst, and L Kalaydjieva
January 1992, Contributions to nephrology,
N Bogdanova, and B Dworniczak, and D Dragova, and V Todorov, and D Dimitrakov, and K Kalinov, and J Hallmayer, and J Horst, and L Kalaydjieva
October 1997, Journal of medical genetics,
N Bogdanova, and B Dworniczak, and D Dragova, and V Todorov, and D Dimitrakov, and K Kalinov, and J Hallmayer, and J Horst, and L Kalaydjieva
January 1989, Progress in clinical and biological research,
N Bogdanova, and B Dworniczak, and D Dragova, and V Todorov, and D Dimitrakov, and K Kalinov, and J Hallmayer, and J Horst, and L Kalaydjieva
January 1986, Transactions of the Association of American Physicians,
N Bogdanova, and B Dworniczak, and D Dragova, and V Todorov, and D Dimitrakov, and K Kalinov, and J Hallmayer, and J Horst, and L Kalaydjieva
August 1987, Human genetics,
N Bogdanova, and B Dworniczak, and D Dragova, and V Todorov, and D Dimitrakov, and K Kalinov, and J Hallmayer, and J Horst, and L Kalaydjieva
April 1995, Human genetics,
N Bogdanova, and B Dworniczak, and D Dragova, and V Todorov, and D Dimitrakov, and K Kalinov, and J Hallmayer, and J Horst, and L Kalaydjieva
January 1989, Clinical genetics,
N Bogdanova, and B Dworniczak, and D Dragova, and V Todorov, and D Dimitrakov, and K Kalinov, and J Hallmayer, and J Horst, and L Kalaydjieva
January 1993, Human genetics,
N Bogdanova, and B Dworniczak, and D Dragova, and V Todorov, and D Dimitrakov, and K Kalinov, and J Hallmayer, and J Horst, and L Kalaydjieva
June 2006, Zhonghua yi xue za zhi,
N Bogdanova, and B Dworniczak, and D Dragova, and V Todorov, and D Dimitrakov, and K Kalinov, and J Hallmayer, and J Horst, and L Kalaydjieva
August 1988, Lancet (London, England),
Copied contents to your clipboard!